LOHAUS, Raphaela, NEUMANN, Franz-Josef, SCHULZ-SCHÜPKE, Stefanie und LOHAUS, Raphaela, 2020. Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis. Freiburg: Universität.
Elsevier - Harvard (with titles)Lohaus, R., Neumann, F.-J., Schulz-Schüpke, S., Lohaus, R., 2020. Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis. Universität, Freiburg. https://doi.org/10.1038/srep33054
American Psychological Association 7th editionLohaus, R., Neumann, F.-J., Schulz-Schüpke, S., & Lohaus, R. (ca. 2020). Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis [Cd]. Universität. https://doi.org/10.1038/srep33054
Springer - Basic (author-date)Lohaus R, Neumann F-J, Schulz-Schüpke S, Lohaus R (2020) Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Lohaus, Raphaela/ Neumann, Franz-Josef/ Schulz-Schüpke, Stefanie/ Lohaus, Raphaela, Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis, Freiburg 2020.